600518 康美药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.1820.1211.465-31.860-2,597.984
总资产报酬率 ROA (%)0.0950.0610.696-17.21932.069
投入资产回报率 ROIC (%)0.1730.1121.199-27.00450.079

边际利润分析
销售毛利率 (%)19.06814.78117.06715.14316.044
营业利润率 (%)0.801-0.4781.778-42.523243.488
息税前利润/营业总收入 (%)0.7860.7682.821-62.754222.028
净利润/营业总收入 (%)0.3810.2332.125-64.443190.725

收益指标分析
经营活动净收益/利润总额(%)-225.162-915.188-18.66726.638-29.026
价值变动净收益/利润总额(%)89.491170.78940.229-0.0282.315
营业外收支净额/利润总额(%)-3.722171.53821.47433.277-23.979

偿债能力分析
流动比率 (X)1.2101.1711.1161.3571.675
速动比率 (X)0.7880.7450.6830.8511.029
资产负债率 (%)47.19947.75450.41853.95937.908
带息债务/全部投入资本 (%)-3.548-4.221-4.363-4.313-4.210
股东权益/带息债务 (%)-2,677.162-2,250.834-2,069.085-1,733.971-2,220.407
股东权益/负债合计 (%)111.280108.88397.88484.895163.111
利息保障倍数 (X)59.1137.6865.070-64.2378.661

营运能力分析
应收账款周转天数 (天)163.843151.277147.504143.032163.071
存货周转天数 (天)209.081209.796240.218301.709459.708